|
| (2S)-5-(diaminomethylideneamino)-2-[[(2S)-2-[(5Z)-5-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]-4-oxo-2-phenylimino-1,3-thiazolidin-3-yl]-3-(4-phenylphenyl)propanoyl]amino]pentanamide |
|
Salmonella |
TTSS (SPI-1 encode) |
Preclinical (in vitro) |
Felise HB, et al. 2008. Cell Host Microbe |
|
| Indole-3-acetic acid |
|
Salmonella |
TTSS (SPI-1 encode) |
Preclinical (in vitro) |
McShan AC, et al. 2016. ChemMedChem |
|
| Fusaric acid |
|
Salmonella |
TTSS (SPI-1 encode) |
Preclinical (in vitro) |
Li J, et al. 2014. Biochem Biophys Res Commun |
|
| N'-[(E)-(3-ethoxy-2-hydroxyphenyl)methylideneamino]oxamide |
|
Salmonella |
TTSS (SPI-1 encode); TTSS (SPI-2 encode) |
Preclinical (in vitro) |
Negrea A, et al. 2007. Antimicrob Agents Chemother |
|
| N'-[(E)-(5-bromo-2-hydroxyphenyl)methylideneamino]oxamide |
|
Salmonella
Shigella |
TTSS (SPI-1 encode); TTSS (SPI-2 encode)
TTSS (Type III secretion system) |
Preclinical (in vitro)
Preclinical (in vitro) |
Negrea A, et al. 2007. Antimicrob Agents Chemother
Veenendaal AK, et al. 2009. J Bacteriol |
|
| (E)-N'-(3,5-Dibromo-2-hydroxybenzylidene)nicotinohydrazide |
|
Chlamydia
Escherichia
Salmonella |
TTSS (Type III secretion system)
TTSS (Type III secretion system)
TTSS (SPI-1 encode); TTSS (SPI-2 encode) |
Preclinical (in vitro)
Preclinical (in vitro)
Preclinical (in vitro) |
Bailey L, et al. 2007. FEBS Lett
Tree JJ, et al. 2009. Infect Immun; Wang D, et al. 2011. J Biol Chem
Negrea A, et al. 2007. Antimicrob Agents Chemother |
|
| Nicotinic acid (5-bromo-2-hydroxy-benzylidene)-hydrazide |
|
Salmonella
Shigella |
TTSS (SPI-1 encode); TTSS (SPI-2 encode)
TTSS (Type III secretion system) |
Preclinical (in vitro)
Preclinical (in vitro) |
Negrea A, et al. 2007. Antimicrob Agents Chemother
Veenendaal AK, et al. 2009. J Bacteriol |
|
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
